Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?

@inproceedings{Aikawa2011IntestinalMA,
  title={Intestinal microsporidiosis: a hidden risk in rheumatic disease patients undergoing anti-tumor necrosis factor therapy combined with disease-modifying anti-rheumatic drugs?},
  author={N{\'a}dia Emi Aikawa and Aline de Oliveira Twardowsky and Joz{\'e}lio Freire de Carvalho and Clovis A Silva and Ivan Leonardo Avelino França e Silva and Ana Cristina de Medeiros Ribeiro and Carla Gonçalves Schain Saad and Julio C{\'e}sar Bertacini Moraes and Roberto Acayaba de Toledo and Elo{\'i}sa Silva Dutra de Oliveira Bonf{\'a}},
  booktitle={Clinics},
  year={2011}
}
OBJECTIVE Immunosuppressed patients are at risk of microsporidiosis, and this parasitosis has an increased rate of dissemination in this population. Our objective was to evaluate the presence of microsporidiosis and other intestinal parasites in rheumatic disease patients undergoing anti-tumor necrosis factor/disease-modifying anti-rheumatic drug treatment. METHODS Ninety-eight patients (47 with rheumatoid arthritis, 31 with ankylosing spondylitis and 11 with psoriatic arthritis) and 92… CONTINUE READING
2 Citations
36 References
Similar Papers

References

Publications referenced by this paper.
Showing 1-10 of 36 references

Clinical significance of enteric protozoa in the immunosuppressed human population

  • D Stark, JL Barratt, S van Hal, D Marriott, J Harkness, JT. Ellis
  • Clin Microbiol Rev. 2009;22:634-50,
  • 2009
Highly Influential
5 Excerpts

Similar Papers

Loading similar papers…